114 related articles for article (PubMed ID: 26373273)
1. The Amazing and Deadly Glioma Race.
Ramaswamy V; Taylor MD
Cancer Cell; 2015 Sep; 28(3):275-7. PubMed ID: 26373273
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.
Mazor T; Pankov A; Johnson BE; Hong C; Hamilton EG; Bell RJA; Smirnov IV; Reis GF; Phillips JJ; Barnes MJ; Idbaih A; Alentorn A; Kloezeman JJ; Lamfers MLM; Bollen AW; Taylor BS; Molinaro AM; Olshen AB; Chang SM; Song JS; Costello JF
Cancer Cell; 2015 Sep; 28(3):307-317. PubMed ID: 26373278
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the Kank1 gene-induced brain glioma apoptosis and blockade of the cell cycle in G0/G1 phase.
Guo X; Fan W; Bian X; Ma D
Int J Oncol; 2014 Mar; 44(3):797-804. PubMed ID: 24399197
[TBL] [Abstract][Full Text] [Related]
4. The DNA methylome of glioblastoma multiforme.
Martinez R; Esteller M
Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
[TBL] [Abstract][Full Text] [Related]
5. Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression.
Alentorn A; Durán-Peña A; Malousi A; Marie Y; Mokhtari K; Sanson M; Hoang-Xuan K; Delattre JY; Idbaih A; Vecht C
J Neurooncol; 2015 Sep; 124(3):385-92. PubMed ID: 26224161
[TBL] [Abstract][Full Text] [Related]
6. An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.
Zhang BL; Liu J; Lei Y; Xiong Y; Li H; Lin X; Yao RQ; Gao DS
Mol Neurobiol; 2016 Sep; 53(7):4352-62. PubMed ID: 26232065
[TBL] [Abstract][Full Text] [Related]
7. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
8. Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors.
Donovan P; Cato K; Legaie R; Jayalath R; Olsson G; Hall B; Olson S; Boros S; Reynolds BA; Harding A
Mol Biosyst; 2014 Apr; 10(4):741-58. PubMed ID: 24448662
[TBL] [Abstract][Full Text] [Related]
9. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtypes of glioma identified by genome-wide methylation profiling.
Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
[TBL] [Abstract][Full Text] [Related]
11. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
12. Predictive biomarkers investigated in glioblastoma.
Tabouret E; Chinot O; Sanson M; Loundou A; Hoang-Xuan K; Delattre JY; Idbaih A
Expert Rev Mol Diagn; 2014 Sep; 14(7):883-93. PubMed ID: 25096963
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
Maury E; Hashizume R
Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.
Zhou Y; Dai W; Wang H; Pan H; Wang Q
Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460
[TBL] [Abstract][Full Text] [Related]
15. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation level of promoter region of activating transcription factor 5 in glioma.
Hua XM; Wang J; Qian DM; Song JY; Chen H; Zhu XL; Zhou R; Zhao YD; Zhou XZ; Li L; Zhang L; Song XX; Wang B
J Zhejiang Univ Sci B; 2015 Sep; 16(9):757-62. PubMed ID: 26365117
[TBL] [Abstract][Full Text] [Related]
17. Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation.
Nguyen SA; Stechishin OD; Luchman HA; Lun XQ; Senger DL; Robbins SM; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Sep; 20(18):4894-903. PubMed ID: 25078279
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
19. The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis.
Lee A; Youssef I; Osborn VW; Safdieh J; Becker DJ; Schreiber D
J Clin Neurosci; 2018 May; 51():85-90. PubMed ID: 29483008
[TBL] [Abstract][Full Text] [Related]
20. [Molecular background of the melanoma and the brain metastasis].
Katona F; Murnyák B; Marko-Varga G; Hortobágyi T
Orv Hetil; 2017 Jul; 158(28):1083-1091. PubMed ID: 28691878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
